v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Revenue $ 9,002 $ 13,037
Cost of revenue 5,756 7,102
Gross profit 3,246 5,935
Operating expenses    
Research and development 1,556 1,432
Sales and marketing 2,332 2,137
General and administrative 1,364 1,534
Intangible amortization 308 990
Total operating expenses 5,560 6,093
Operating profit (loss) (2,314) (158)
Other income, net 164 119
Income (loss) before income taxes (2,150) (39)
Income tax benefit (expense) (7) 0
Net income (loss) (1) [1] $ (2,157) $ (39)
Net income (loss) per share:    
Basic $ (0.14) $ 0.00
Diluted $ (0.14) $ 0.00
Weighted-average number of common shares outstanding:    
Basic (shares) 15,455 15,632
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options (2) [2] 0 0
Diluted (shares) 15,455 15,632
Product [Member]    
Revenue $ 7,815 $ 11,789
Service [Member]    
Revenue $ 1,168 $ 832
[1] Net income (loss) and comprehensive income (loss) are the same for the periods reported.
[2] The Company had 1.0 million and 1.0 million shares represented by common stock equivalents for the three months ended June 30, 2019, and June 30, 2018, respectively, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation.

Source